-

ORPEA Has Filed a Complaint Against the Group’s former Chief executive officer Yves le Masne

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

On 20 December 2022, ORPEA (Paris:ORP) filed a new complaint, this time against Yves Le Masne, for charges likely to represent misappropriation of company assets or funds, breach of trust, complicity, concealment or laundering.

Yves le Masne was appointed Deputy Chief Executive Officer in 2006, then Chief Executive Officer in 2010.
On 30 January 2022, the Board of Directors terminated his duties as Chief Executive Officer.

This complaint comes after an initial complaint against unnamed persons, filed in April 2022 and regularly supplemented by the company, relating to the actions of certain former managers or employees.

ORPEA is conducting further investigations and will work, as the case may be, on additional complaints that may be filed against the parties concerned. Moreover, it will continue to bring any findings of financial malpractice to the attention of the Public Prosecutor of Nanterre.

About ORPEA
ORPEA is a leading global player, expert in the care of all types of frailty. The Group operates in 22 countries and covers three core businesses: care for the elderly (nursing homes, assisted living, home care), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 72,000 employees and welcomes more than 255,000 patients and residents each year.
https://www.orpea-group.com/
ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Contacts

Press
Isabelle HERRIER NAUFLE
Public Relations Director
Phone: +33 7 70 29 53 74
i.herrier-naufle@orpea.net

Jean Baptiste ROUSSILLE
Director of Investor Relations
Phone: +33 7 88 50 21 60
j-b.roussille@orpea.net

Charlotte LE BARBIER
Image 7
Phone: +33 6 78 37 27 60
clebarbier@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Press
Isabelle HERRIER NAUFLE
Public Relations Director
Phone: +33 7 70 29 53 74
i.herrier-naufle@orpea.net

Jean Baptiste ROUSSILLE
Director of Investor Relations
Phone: +33 7 88 50 21 60
j-b.roussille@orpea.net

Charlotte LE BARBIER
Image 7
Phone: +33 6 78 37 27 60
clebarbier@image7.fr

More News From ORPEA

emeis Announces Its Early Exit From the Accelerated Safeguard Plan

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) announces its early exit from the accelerated safeguard plan on February 20, 2026, following the approval of its request by the Nanterre Economic Court. This early exit, achieved in record time, was made possible by: - the implementation of a major disposal plan (€2.45 billion in disposals completed or secured since mid-2022) - the strengthening of emeis S.A.'s balance sheet structure since December 18, 2025 with the raising...

emeis: Activity and revenue at the end of 2025 (unaudited)1

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS): Laurent Guillot, Chief Executive Officer: "We are proud of our performance in 2025, with results that demonstrate that we are delivering on our commitments and in line with our strategy. The recent announcement of the creation of our property company Isemia, the completion of our disposal plan and the strengthening of our balance sheet structure already allow us to anticipate an accelerated exit from the safeguard plan in r...

emeis Announces the Creation of Isemia, a Real Estate Company Dedicated to Healthcare Real Estate in Europe

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: In accordance with the agreements signed and announced on September 23, 2025, emeis (Paris:EMEIS) announces the creation of Isemia, its healthcare real estate company dedicated to healthcare real estate assets operated by the Group, with its partners Farallon Capital and TwentyTwo Real Estate. emeis has thus received €761 million from its partners, representing 62% of the last appraised value1 of the assets held by this vehicle, thereby immedia...
Back to Newsroom